275 related articles for article (PubMed ID: 23523543)
1. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice.
Pali-Schöll I; Szöllösi H; Starkl P; Scheicher B; Stremnitzer C; Hofmeister A; Roth-Walter F; Lukschal A; Diesner SC; Zimmer A; Jensen-Jarolim E
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):656-64. PubMed ID: 23523543
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma.
Mousavi T; Salek Moghadam A; Falak R; Tebyanian M
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305
[TBL] [Abstract][Full Text] [Related]
4. Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen.
Jahn-Schmid B; Wiedermann U; Bohle B; Repa A; Kraft D; Ebner C
J Allergy Clin Immunol; 1999 Nov; 104(5):1015-23. PubMed ID: 10550747
[TBL] [Abstract][Full Text] [Related]
5. Induction of a Th1 immune response and suppression of IgE via immunotherapy with a recombinant hybrid molecule encapsulated in liposome-protamine-DNA nanoparticles in a model of experimental allergy.
Nouri HR; Varasteh A; Jaafari MR; Davies JM; Sankian M
Immunol Res; 2015 Jul; 62(3):280-91. PubMed ID: 25957889
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles.
Kerkmann M; Lochmann D; Weyermann J; Marschner A; Poeck H; Wagner M; Battiany J; Zimmer A; Endres S; Hartmann G
Oligonucleotides; 2006; 16(4):313-22. PubMed ID: 17155907
[TBL] [Abstract][Full Text] [Related]
7. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
8. IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN.
Fonseca DM; Paula MO; Wowk PF; Campos LW; Gembre AF; Turato WM; Ramos SG; Dias-Baruffi M; Barboza R; Gomes E; Horn C; Marchal G; Arruda LK; Russo M; Bonato VL
Immunol Cell Biol; 2011 Oct; 89(7):777-85. PubMed ID: 21403663
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.
Farkas L; Kvale EO; Johansen FE; Jahnsen FL; Lund-Johansen F
J Allergy Clin Immunol; 2004 Aug; 114(2):436-43. PubMed ID: 15316529
[TBL] [Abstract][Full Text] [Related]
10. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of Chenopodium album induced asthma by intranasal administration of CpG oligodeoxynucleotides in BALB/c mice.
Mousavi T; Salek Moghadam A; Falak R
Iran J Immunol; 2008 Mar; 5(1):57-63. PubMed ID: 18319526
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.
Grönlund H; Vrtala S; Wiedermann U; Dekan G; Kraft D; Valenta R; Van Hage-Hamsten M
Immunology; 2002 Dec; 107(4):523-9. PubMed ID: 12460198
[TBL] [Abstract][Full Text] [Related]
13. Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy.
Heo MB; Kim SY; Yun WS; Lim YT
Int J Nanomedicine; 2015; 10():5981-92. PubMed ID: 26451105
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
Vasilakos JP; Smith RM; Gibson SJ; Lindh JM; Pederson LK; Reiter MJ; Smith MH; Tomai MA
Cell Immunol; 2000 Aug; 204(1):64-74. PubMed ID: 11006019
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice.
Kohama Y; Akizuki O; Hagihara K; Yamada E; Yamamoto H
J Allergy Clin Immunol; 1999 Dec; 104(6):1231-8. PubMed ID: 10589006
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.
Tighe H; Takabayashi K; Schwartz D; Van Nest G; Tuck S; Eiden JJ; Kagey-Sobotka A; Creticos PS; Lichtenstein LM; Spiegelberg HL; Raz E
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):124-34. PubMed ID: 10887315
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
18. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
Becker Y
Virus Genes; 2005 Mar; 30(2):251-66. PubMed ID: 15744581
[TBL] [Abstract][Full Text] [Related]
19. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen.
Hartl A; Kiesslich J; Weiss R; Bernhaupt A; Mostböck S; Scheiblhofer S; Ebner C; Ferreira F; Thalhamer J
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):107-13. PubMed ID: 9893193
[TBL] [Abstract][Full Text] [Related]
20. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses.
Trujillo-Vargas CM; Ramirez-Pineda JR; Palmetshofer A; Grunewald S; Moll H; Berberich C; Erb KJ
Int Arch Allergy Immunol; 2005 Jul; 137(3):219-28. PubMed ID: 15956790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
